Table 1 Baseline characteristics of all patients with pancreatic cancer
From: Time interval-based indication for liver resection of metastasis from pancreatic cancer
(n = 79) | ||
|---|---|---|
Age | (years) | 66 (41–83) |
Primary operation | (%) | |
pancreaticoduodenectomy | 50 (63.3) | |
Distal pancreatectomy | 28 (35.4) | |
Total pancreatectomy | 1 (1.3) | |
TMN classification stage | (%) | |
IA | 4 (5.1) | |
IB | 6 (7.6) | |
IIA | 24 (30.4) | |
IIB | 18 (22.7) | |
III | 26 (32.9) | |
IV | 1 (1.3) | |
Serum bilirubin | (IU/L) | 0.69 (0.2–11.7) |
Serum albumin | (IU/L) | 4.0 (3.5–4.9) |
Carcinoembryonic antigen | (IU/L) | 3.85 (0.6–255) |
Carbohydrate antigen 19-9 | (IU/L) | 104.9 (0.1–13,820) |
Operation time | (min) | 446 (193–738) |
Intraoperative blood loss | (ml) | 370 (25–1720) |
Adjuvant chemotherapy after pancreatectomy | (%) | 20 (25) |